Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-16 Purchase |
2022-05-17 11:04 am |
Unicycive Therapeutics Inc. | UNCY | Schiller Brigitte Director |
15,000 | $0.825 | $12,375 | 15,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Conversion |
2025-02-19 11:55 am |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
1,400,000 | $0 | 11,373,271 (Indirect) |
View |
| 2024-10-09 Conversion |
2024-10-10 5:15 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
5,500,000 | $0 | 9,974,037 (Indirect) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:15 pm |
N/A 2034-08-12 |
Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer |
40,256 | $0 | 915,565 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:15 pm |
N/A 2034-08-12 |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
81,750 | $0 | 2,119,862 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:15 pm |
N/A 2034-08-12 |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
81,750 | $0 | 2,055,000 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:15 pm |
N/A 2034-08-12 |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
232,868 | $0 | 6,439,505 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 4:33 pm |
N/A 2034-04-15 |
Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer |
228,119 | $0 | 875,309 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 4:32 pm |
N/A 2034-04-15 |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
463,250 | $0 | 1,973,250 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 4:31 pm |
N/A 2034-04-15 |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
463,250 | $0 | 2,038,112 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 4:31 pm |
N/A 2034-04-15 |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO 10% Owner |
1,319,583 | $0 | 6,206,637 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:34 pm |
N/A 2033-09-05 |
Unicycive Therapeutics Inc. | UNCY | Laumas Sandeep Director |
189,236 | $0 | 200,864 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:33 pm |
2024-09-05 2033-09-05 |
Unicycive Therapeutics Inc. | UNCY | Kenkare-Mitra Sara Director |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:32 pm |
N/A 2033-09-05 |
Unicycive Therapeutics Inc. | UNCY | Ryan John L Director |
112,147 | $0 | 123,775 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:30 pm |
2024-09-05 2033-09-05 |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-08-28 Option Award |
2023-08-30 4:47 pm |
N/A 2033-08-28 |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
1,355,000 | $0 | 1,574,862 (Direct) |
View |
| 2023-08-28 Option Award |
2023-08-30 4:47 pm |
N/A 2033-08-28 |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
4,684,775 | $0 | 4,988,798 (Direct) |
View |
| 2023-08-28 Option Award |
2023-08-30 4:46 pm |
N/A 2033-08-28 |
Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer |
570,329 | $0 | 647,190 (Direct) |
View |
| 2023-08-28 Option Award |
2023-08-30 4:45 pm |
N/A 2033-08-28 |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
1,355,000 | $0 | 1,510,000 (Direct) |
View |
| 2023-07-11 Conversion |
2023-07-13 8:42 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
8,077 | $1000 | 59,961,729 (Indirect) |
View |
| 2023-07-11 Conversion |
2023-07-13 8:42 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
59,961,729 | $0 | 59,961,729 (Indirect) |
View |
| 2023-07-11 Exercise |
2023-07-13 7:33 pm |
2023-07-11 N/A |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
371,186 | $0 | 441,586 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-13 7:33 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
50 | $1000 | 441,586 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-13 7:01 pm |
2023-07-11 N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
148,473 | $0 | 148,473 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-13 7:01 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
20 | $1000 | 148,473 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-13 6:10 pm |
2023-07-11 N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
371,186 | $0 | 2,794,023 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-13 6:10 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
50 | $1000 | 2,794,023 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-09 9:39 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
8,077 | $1000 | 8,077 (Indirect) |
View |
| 2023-03-08 Option Award |
2023-03-09 9:37 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
50 | $1000 | 50 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-09 9:35 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
20 | $1000 | 20 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-09 9:32 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
50 | $1000 | 50 (Direct) |
View |
| 2022-11-21 Option Award |
2022-11-23 08:00 am |
N/A 2032-11-21 |
Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer |
35,000 | $0 | 76,861 (Direct) |
View |
| 2022-11-21 Option Award |
2022-11-23 08:00 am |
N/A 2032-11-21 |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
55,000 | $0 | 155,000 (Direct) |
View |
| 2022-11-21 Option Award |
2022-11-23 08:00 am |
N/A 2032-11-21 |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
86,000 | $0 | 202,279 (Direct) |
View |
| 2022-11-21 Option Award |
2022-11-23 08:00 am |
N/A 2032-11-21 |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
28,000 | $0 | 219,862 (Direct) |
View |
Ownership |
2022-11-21 08:51 am |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy |
0 | $0 | 170,400 (Direct) |
View |
| 2022-07-15 Exercise |
2022-08-30 5:01 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Schiller Brigitte Director |
26,738 | $0 | 26,738 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-26 4:15 pm |
N/A 2031-07-15 |
Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO |
116,279 | $0 | 218,023 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-26 4:15 pm |
N/A 2031-07-15 |
Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD |
34,884 | $0 | 191,862 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-26 4:15 pm |
N/A 2031-07-15 |
Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer |
18,605 | $0 | 41,861 (Direct) |
View |
Ownership |
2021-07-12 5:15 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Ryan John L Director |
0 | $0 | 69,768 (Direct) |
View |